Home > Tokyo stocks briefly rise over 500 points on expectation for COVID-19 vaccine development

Business
Tokyo stocks briefly rise over 500 points on expectation for COVID-19 vaccine development

Description

Tokyo, May 19 (EFE/EPA).- The Tokyo stock benchmark Nikkei briefly rose over 500 points during the trading on Tuesday due to expectation for vaccine development of the COVID-19 coronavirus, before ending at 20,433.45 points, up 299.72 points or 1.49 percent(Camera: KIMIMASA MAYAMA).FOOTAGE SHOWS PEDESTRIANS WALKING PAST A SCREEN SHOWING CLOSING INFORMATION OF TOKYO'S NIKKEI STOCK AVERAGE, WHILE THE JAPANESE CAPITAL IS STILL UNDER CORONAVIRUS STATE OF EMERGENCY, IN TOKYO, JAPAN.

Added on the 19/05/2020 14:00:00 - Copyright : EFE Inglés

To customise your video :

Or Create an account

More videos on the subject

  • Dow Up Over 200 Points On Anticipation Of Stimulus

    On Monday, US stocks rallied as investors bet on the distribution of Pfizer's COVID-19 vaccine and stimulus progress to lift the economy. According to Business Insider, a bipartisan $908 billion stimulus proposal is set to be formally unveiled on Monday. One package will include $748 billion in funds for highly supported measures. A smaller package including more controversial state and local government aid and liability protections for businesses. On Monday, Pfizer and BioNTech will deliver their coronavirus vaccine. Oil prices ticked higher after a tanker exploded in a Saudi Arabian port. West Texas Intermediate crude gained as much as 1.9%, to $47.44 per barrel.

    14/12/2020 - Wochit
  • Nikkei rises 2.5 percent in expectation of early development of COVID-19 vaccine

    Tokyo (Stock Exchange), Nov 24 (EFE / EPA).- The Tokyo stock benchmark soared 638.22 points or 2.5 percent to close at 26,165.59 in expectation of early development of vaccine for the COVID-19 coronavirus. (Camera: KIMIMASA MAYAMA)SHOT LIST: A DISPLAY SHOWING CLOSING INFORMATION OF THE NIKKEI STOCK AVERAGE IN TOKYO, JAPAN.

    24/11/2020 - EFE Inglés
  • Dow Jumps 210 Points On Vaccine News From AstraZeneca

    On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%

    23/11/2020 - Wochit
  • Netflix Drops 9% After Vaccine News

    On Monday, phrama giant Pfizer revealed positive COVID-19 vaccine news. The news sent shares of stay-at-home stocks like Netflix plummeting on Monday. Netflix itself fell as much as 9%, even as major indexes like the S&P 500 and Dow Jones industrial average soared to record highs. Consumers flocked to entertainment alternatives amid the lengthy stay-at-home orders. Netflix saw a spike in subscribers due to the COVID-19 pandemic.

    09/11/2020 - Wochit

More videosBusiness

Watch video of The Post-Brexit Recovery Across European Markets Has Stalled With Major Share Indexes Mixed And Safe-haven Demand For Precious Metals Helping The Price Of Silver Surge To A Near-two Year High.  But,  As Sonia Legg Reports, Trading Volumes Were Light Becasue Of The July 4 Public Holiday In The United States. - European shares end post-Brexit rally - Label : Reuters EN -
Business

European shares end post-Brexit rally

04/07/2016 15:56:29

Watch video of BP Slumps To Its Worst Annual Loss In 2015, The British Oil And Gas Company Announces, And Says It Will Cut Thousands More Jobs In The Face Of A Deep Rout In Oil Prices. Hayley Platt Reports - Oil prices drag BP to worst annual loss - Label : Reuters EN -
Business

Oil prices drag BP to worst annual loss

02/02/2016 14:51:34